基因融合在结构变异中的致病性预测:一个知识图注入可解释的人工智能 (XAI) 框架
Katsuhiko Murakami1, Shin-Ichiro Tago1, Sho Takishita1
1Computing Laboratories, Fujitsu Research, Fujitsu Ltd., Kawasaki 211-8588, Kanagawa, Japan.
Cancers
|May 25, 2024
概括
这项研究引入了一种可解释的AI (XAI),用于识别癌症基因组中的基因融合的驱动结构变异 (SV). 该XAI提供准确的预测,并解释他们的推理,帮助基因组医学可靠的诊断.
科学领域:
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
- 人工智能的人工智能
背景情况:
- 癌症基因组分析揭示了除单核酸变异 (SNV) 外的众多结构变异 (SV).
- 鉴定驱动变异,特别是那些涉及基因融合的变异,对于临床实践来说是具有挑战性的.
- 准确的人工智能 (AI) 预测对于选择驱动器变体和提高诊断可靠性至关重要.
研究的目的:
- 开发一种可解释的AI (XAI) 模型,用于预测涉及基因融合的SVs的病原性.
- 增强人工智能驱动的基因组分析,以便更可靠的癌症诊断.
- 通过扩展知识图和完善算法,为具有基因融合的SVs适应现有的XAI技术.
主要方法:
- 基于SNV病原性预测的先前工作开发可解释AI (XAI).
- 增强知识图表,增加了针对SVs和基因融合的新数据.
- 改进人工智能算法来处理复杂的基因融合变体.
- 与现有工具对预测准确性的验证.
主要成果:
- 开发的XAI实现了与基因融合的SVs现有工具可比的预测准确度.
- XAI成功地为其预测提供了解释,详细说明了变种致病性背后的推理.
- 通过使用变体示例,证明了关于基本致病机制的解释是合理的.
结论:
- XAI为识别癌症中具有基因融合的驱动SV提供了有前途的方法.
- 可解释性功能提高了基因组医学中人工智能驱动的诊断的可靠性.
- 这项工作代表了人工智能支持的癌症基因组学临床决策的重大进展.
相关概念视频
01:24Tagging and Fusion Proteins
6.6K
Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
6.6K
02:18Types of Genetic Transfer Between Organisms
27.8K
Genetic transfer occurs when genetic information is passed from one organism to another. It occurs via two mechanisms: vertical gene transfer and horizontal gene transfer. Vertical gene transfer occurs when genetic information is transferred from one generation to the next, which happens much more frequently than horizontal gene transfer. Both sexual and asexual reproduction are forms of vertical gene transfer, where one or more organisms pass some or all of their genome onto their progeny.
27.8K
01:11Genome-wide Association Studies-GWAS
13.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.3K
00:59Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
00:57Viral Recombination
23.4K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.4K
00:36Viral Mutations
32.3K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.3K